You are viewing the site in preview mode

Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

Non hepatitis jaundice - adverse reaction to rifampicin

  • 1Email author,
  • 2,
  • 1 and
  • 3
BMC Infectious Diseases201414 (Suppl 7) :P48

  • Published:


  • Tuberculosis
  • Bilirubin
  • Bile Acid
  • Rifampicin
  • Chronic Renal Failure


The hopes placed in the new treatment regimens for tuberculosis (TB), with the emergence of rifampicin were partially shaded by the side effects which were frequently recorded, able to impose temporary or definitive abandonment of this tuberculostatic.

Case report

The patient to be presented illustrates relapse of TB infection, in the context of significant comorbidities: chronic renal failure, uremic stage, in chronic hemodialysis program; primary hyperuricemia with urate nephropathy; stage II arterial hypertension with very high cardiovascular risk.

In the absence of clinical, definite biological and morphological criteria, the diagnosis of drug hepatopathy relies predominantly on causal relationship between the drug administration and the occurrence of the therapeutic accident. Non-hepatitis jaundice (liver tests normal) occurred after 2 weeks of daily tuberculosis treatment, suggesting the involvement of rifampicin in the conjugation of bilirubin and conjugated bilirubin excretion in the bile. The peculiarity of the case: In the patient presented, the fundamental mechanism behind the cholestatic syndrome consisted of: compromising the active transport of bilirubin through the liver cell, without being present the reflux of bile constituents (e.g., bile acids) in the circulation.


Adverse reactions to drugs due to their frequency and harmfulness have opened a new nosology chapter in modern medicine. Adverse effects of tuberculostatic drugs affect in a negative way both the management and the dynamics of TB infection.


Authors’ Affiliations

Dr. Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania
Dr. Victor Babeş Clinical Hospital of Infectious Diseases and Pneumology, Timişoara, Romania
Clinical Emergency Children’s Hospital “Dr. L. Turcanu”, Timişoara, Romania


© Laza et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.